The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Chekanova E.O.

Research Center of Neurology

Simaniv T.O.

Research Center of Neurology

Evdokimenko A.N.

Research Center of Neurology

Zakharova M.N.

Research Center of Neurology

Anti-Ma2 paraneoplastic autoimmune encephalitis

Authors:

Chekanova E.O., Simaniv T.O., Evdokimenko A.N., Zakharova M.N.

More about the authors

Read: 4311 times


To cite this article:

Chekanova EO, Simaniv TO, Evdokimenko AN, Zakharova MN. Anti-Ma2 paraneoplastic autoimmune encephalitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(7‑2):89‑95. (In Russ.)
https://doi.org/10.17116/jnevro202212207289

References:

  1. Vogrig A, Gigli GL, Segatti S, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267(1):26-35.  https://doi.org/10.1007/s00415-019-09544-1
  2. Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007;2:22-28.  https://doi.org/10.1186/1750-1172-2-22
  3. Rees JH. Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage. J Neurol Neurosurg Psychiatry. 2004;75(suppl 2):43-50.  https://doi.org/10.1136/jnnp.2004.040378
  4. Graus F, Vogrig A, Muñiz-Castrillo S, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014. https://doi.org/10.1212/NXI.0000000000001014
  5. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543-1554. https://doi.org/10.1056/NEJMra023009
  6. Siles AM, Martínez-Hernández E, Araque J, et al. Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies. Ann Clin Transl Neurol. 2018;5:559-569.  https://doi.org/10.1002/acn3.554
  7. Giometto B, Grisold W, Vitaliani R, et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67:330-335.  https://doi.org/10.1001/archneurol.2009.341
  8. Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127(Pt 8):1831-1844. https://doi.org/10.1093/brain/awh203
  9. Yamamoto T, Tsuji S. Anti-MA2-associated encephalitis and paraneoplastic limbic encephalitis. Brain Nerve. 2010;62(8):838-851. 
  10. Ortega Suero G, Sola-Valls N, Escudero D, et al. Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes. Neurologia (Engl Ed). 2018;33(1):18-27.  https://doi.org/10.1016/j.nrl.2016.05.010
  11. Hoffmann LA, Jarius S, Pellkofer HL, et al. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry. 2008;79(7):767-773.  https://doi.org/10.1136/jnnp.2007.118588
  12. Vogrig A, Joubert B, Maureille A, et al. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome. J Neurol. 2019;266(2):398-410.  https://doi.org/10.1007/s00415-018-9143-x
  13. Ayrignac X, Castelnovo G, Landrault E, et al. Ma2 antibody and multiple mononeuropathies. Rev Neurol (Paris). 2008;164(6-7):608-611.  https://doi.org/10.1016/j.neurol.2008.03.005
  14. Murphy SM, Khan U, Alifrangis C, et al. Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes. J Neurol Neurosurg Psychiatry. 2012;83(2):232-233.  https://doi.org/10.1136/jnnp.2010.223271
  15. Compta Y, Iranzo A, Santamaría J, et al. REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep. 2007;30(6):767-769.  https://doi.org/10.1093/sleep/30.6.767
  16. Guo Y, Cai MT, Lai QL, et al. Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study. Brain Sci. 2021;11(12):1577. https://doi.org/10.3390/brainsci11121577
  17. Antoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol. 2017;30(5):513-520.  https://doi.org/10.1097/WCO.0000000000000475
  18. Piccolo G, Tavazzi E, Jarius S, et al. Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome. Neurol Sci. 2011;32(5):915-917.  https://doi.org/10.1007/s10072-011-0510-y
  19. Waragai M, Chiba A, Uchibori A, et al. Anti-Ma2 associated paraneoplastic neurological syndrome presenting as encephalitis and progressive muscular atrophy. J Neurol Neurosurg Psychiatry. 2006;77(1):111-113.  https://doi.org/10.1136/jnnp.2005.068775
  20. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404.  https://doi.org/10.1016/S1474-4422(15)00401-9
  21. Rosenfeld MR, Eichen JG, Wade DF, et al. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol. 2001;50(3):339-348. 
  22. Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and management. J Neurol Neurosurg Psychiatry. 2021;92(7):757-768.  https://doi.org/10.1136/jnnp-2020-325300
  23. Pellkofer H, Schubart AS, Höftberger R, et al. Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain. 2004;127(Pt 8):1822-1830. https://doi.org/10.1093/brain/awh205
  24. Abboud H, Probasco J, Irani SR, et al. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021;92(8):897-907.  https://doi.org/10.1136/jnnp-2020-325302

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.